Marimaca Copper Identifies Large Surface Geochemical Anomaly at Cindy Target
February 17, 2021 07:36 ET
|
Marimaca Copper Corp.
VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”)(TSX: MARI) is pleased to announce the results of a recently completed rock...
Global Airport Security Market Report 2021: Growth Opportunities in COVID-19 Prevention, Screening and Detection, Cybersecurity, Surveillance, Data Analytics
February 17, 2021 07:33 ET
|
Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Vendors Offer New Digitized Solutions to Drive the Global Airport Security Market" report has been added to ResearchAndMarkets.com's offering. As...
Travel Arrangement And Reservation Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030
February 17, 2021 07:33 ET
|
ReportLinker
New York, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Travel Arrangement And Reservation Services Global Market Report 2021: COVID 19 Impact and Recovery...
PureK Holdings Corp. Signs Definitive Agreement to Acquire ‘BudaPets’ All-Natural Pet Wellness Brand
February 17, 2021 07:30 ET
|
PureK Holdings Corp.
VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company" or "PureK") (TSX Venture: PKAN) is pleased to announce that it has executed a definitive agreement...
Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review
February 17, 2021 07:30 ET
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) announced that the United States Food and Drug Administration (“FDA”) has...
Salarius Completes Dose-Escalation Stage of Phase 1/2 Clinical Trial in Relapsed and Refractory Ewing Sarcoma Patients, Initiates Expansion Stage in Ewing and Ewing-Related Sarcoma Patients
February 17, 2021 07:30 ET
|
Salarius Pharmaceuticals, Inc.
Seclidemstat safety profile affirmed; Recommended Phase 2 dose established Demonstrated preliminary evidence of seclidemstat drug activity in subset of Ewing-related sarcoma patients HOUSTON, Feb. ...
Innovative Payment Solutions, Inc. Closes $2 Million Dollars Financing from Current Institutional Investors
February 17, 2021 07:30 ET
|
Innovative Payment Solutions, Inc.
NORTHRIDGE, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovative Payment Solutions, Inc. (OTCQB: IPSI) (“Innovative” or the “Company”), a Southern California based fintech company...
Applied Materials to Participate at Morgan Stanley Technology, Media and Telecom Conference
February 17, 2021 07:30 ET
|
Applied Materials, Inc.
SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Applied Materials, Inc. announced today that Dan Durn, Senior Vice President and CFO, will participate in a fireside chat at the virtual Morgan...
Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases
February 17, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
February 17, 2021 07:30 ET
|
Verrica Pharmaceuticals Inc.
- PDUFA goal date assigned is June 23, 2021 - - VP-102 (cantharidin 0.7% Topical Solution) could potentially be the first FDA-approved treatment for molluscum contagiosum, a highly contagious...